14 October 2026 - 15 October 2026
5020 Suarlée, Belgium
Business Village Ecolys Avenue d’Ecolys, 2
Nuclear Medicine in Belgium
Registration open until 9 Oct 2026
Why attend this international event?
Belgium stands out as one of the most advanced and integrated hubs for nuclear medicine in Europe, boasting a comprehensive value chain that spans from research and development to patient delivery.
Participating in Nuclear Medicine in Belgium provides a rare opportunity to strategically engage with key stakeholders and foster high-value international collaborations.
Scheduled strategically just before the European Association of Nuclear Medicine (EANM) Global Annual Congress, this initiative promises an exceptional immersive experience featuring:
A Two-Day Immersive Program: Engage in a dynamic agenda that combines insightful industrial site visits with strategic discussions.
Direct Access to Senior Decision-Makers: Network with influential leaders across the entire nuclear medicine value chain.
Expert Insights: Benefit from keynote testimonials and presentations by Key Opinion Leaders (KOLs) on the latest industry trends and advancements.
Targeted B2B Meetings: Participate in exclusive networking opportunities designed to facilitate valuable connections and collaborations.
Join us to unlock the full potential of nuclear medicine in Belgium and elevate your international partnerships!

DAY 1 - October 14
A rare opportunity to access critical infrastructure shaping the future of advanced radiopharmaceuticals:
Full Life Technologies Europe (Gembloux) - A brand-new state-of-the-art facility dedicated to the production and processing of actinium-225 — a cornerstone for the next generation of targeted alpha therapies.
Telix Pharmaceuticals (Seneffe)
A global radiopharmaceutical company focused on precision oncology. It's Seneffe site serves as a major european production and Innovation hub.
IRE – Institute for Radioelements (Fleurus) - A global leader in medical isotope production. A unique opportunity to discover their newly acquired IBA cyclotron strengthening Germanium-68 production, along with their new CDMO capabilities.

DAY 2 - October 15
High-Level Seminar & Strategic Discussions
Access one of the world’s most integrated nuclear medicine ecosystems in a single day — and identify concrete entry points for collaboration.
This high-level seminar brings together industry leaders, clinicians, researchers, regulators, clusters, and public authorities to discuss the latest trends and strategic developments in the field of nuclear medicine.
Strategic focus areas:
Innovation & Scale-Up – Through business case presentations and roundtables with C-level leaders, participants will explore how innovations move from R&D to clinical translation and industrial deployment in nuclear medicine.
Talent & Awareness– Experts will discuss practical strategies to close the talent gap and strengthen the global visibility and attractiveness of the nuclear medicine field.
Regulation & Market Access – Industry leaders and regulators will exchange perspectives to streamline regulatory pathways and accelerate international market access for innovative solutions.
Ecosystem Power – Discover how coordinated clusters and partnerships will transform regional excellence into European leadership with global impact.


It's time to
15
Sessions